XERIANT, Inc. (XERI) intrinsic value & 10-year financials
XERIANT, Inc. (XERI) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.01
- Market cap
- $5.6M
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- -81.3%
- ROIC (10-yr avg)
- 18734.2%
- Free cash flow (FY2025)
- -$1.3M
XERI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$1.6M | $0.00 | -$1.3M | — | 22.3% |
| FY2024 | — | -$3.1M | -$0.01 | -$1.4M | — | 37.3% |
| FY2023 | — | -$7.1M | — | -$1.2M | — | 285.2% |
| FY2022 | — | -$15.9M | -$0.05 | -$6.9M | — | 2533.2% |
| FY2021 | — | -$2.7M | -$0.01 | -$1.0M | — | 184189.4% |
| FY2020 | — | -$699.6K | — | — | — | 24.8% |
| FY2019 | — | -$4.4M | — | — | — | 144.5% |
| FY2018 | $79.7K | -$838.4K | -$0.01 | — | -585.1% | 23.0% |
| FY2017 | $630.0K | -$1.1M | -$0.02 | — | -107.6% | 37.3% |
| FY2016 | $2.3M | -$1.1M | -$0.02 | $227.9K | -36.0% | 44.9% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
XERIANT, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
XERIANT, INC. has earned high returns on invested capital, averaging 220.4% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
XERIANT, INC. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, XERIANT, INC. is modeled at -81.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.00 per share.